De Maria et al., 2001 - Google Patents
Identification, molecular cloning and functional characterization of NKp46 and NKp30 natural cytotoxicity receptors in Macaca fascicularis NK cellsDe Maria et al., 2001
View PDF- Document ID
- 14036570368532644103
- Author
- De Maria A
- Biassoni R
- Fogli M
- Rizzi M
- Cantoni C
- Costa P
- Conte R
- Mavilio D
- Ensoli B
- Cafaro A
- Moretta A
- Moretta L
- Publication year
- Publication venue
- European journal of immunology
External Links
Snippet
Natural killer (NK) cell recognition and function in humans is regulated by multiple cell surface receptors. The" on" signal leading to NK cell triggering is primarily mediated by natural cytotoxicity receptors (NCR). Analysis of NK cells in primate animal models is of …
- 210000000822 Killer Cells, Natural 0 title abstract description 93
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| De Maria et al. | Identification, molecular cloning and functional characterization of NKp46 and NKp30 natural cytotoxicity receptors in Macaca fascicularis NK cells | |
| US20220348627A1 (en) | Chimeric nk receptor and methods for treating cancer | |
| US11407802B2 (en) | Compositions and methods of chimeric autoantibody receptor T cells | |
| CN107207621B (en) | Chimeric proteins | |
| Conrad et al. | A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes | |
| CN107960056B (en) | Occludin-18.2 specific immunoreceptor and T cell epitopes | |
| US20240158506A1 (en) | Methods to protect transplanted tissue from rejection | |
| Berger et al. | Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK–modified donor T cells after allogeneic hematopoietic cell transplantation | |
| CN107531800B (en) | Lentiviral vectors for regulated expression of chimeric antigen receptor molecules | |
| Marcenaro et al. | CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell‐mediated cytotoxicity | |
| Mazzarino et al. | Identification of effector‐memory CMV‐specific T lymphocytes that kill CMV‐infected target cells in an HLA‐E‐restricted fashion | |
| Mavilio et al. | Identification of NKG2A and NKp80 as specific natural killer cell markers in rhesus and pigtailed monkeys | |
| KR20210031898A (en) | Co-receptor system to treat infectious diseases | |
| CN114230658B (en) | Novel coronavirus specific T cell receptor and uses thereof | |
| CN113727720A (en) | Chimeric antigen receptor modified cells for the treatment of CLDN6 expressing cancers | |
| Biassoni et al. | Molecular and functional characterization of NKG2D, NKp80, and NKG2C triggering NK cell receptors in rhesus and cynomolgus macaques: monitoring of NK cell function during simian HIV infection | |
| Ogawa et al. | Natural killer cells recognize friend retrovirus-infected erythroid progenitor cells through NKG2D–RAE-1 interactions in vivo | |
| US10081663B2 (en) | Affinity maturated T cell receptors and use thereof | |
| US20240226297A9 (en) | Targeting t regulatory cells to islet cells to stall or reverse type 1 diabetes | |
| KR20220007675A (en) | Compositions and methods of acetylcholine receptor chimeric autoantibody receptor cells | |
| Qian et al. | Engineered regulatory T cells coexpressing MHC class II: peptide complexes are efficient inhibitors of autoimmune T cell function and prevent the development of autoimmune arthritis | |
| Mao et al. | CD8+ and CD20+ lymphocytes cooperate to control acute simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys: modulation by major histocompatibility complex genotype | |
| Rutjens et al. | CD8+ NK cells are predominant in chimpanzees, characterized by high NCR expression and cytokine production, and preserved in chronic HIV‐1 infection | |
| Shirwan et al. | Rejection of cardiac allografts by T cells expressing a restricted repertoire of T‐cell receptor Vβ genes | |
| Shieh | The role of natural killer cells in simian immunodeficiency virus (SIV) and human immunodeficiency virus (HIV) infection |